The COVID -19 pandemic has created an unprecedented challenge for pharmaceutical companies. Being a heavily regulated industry, it is important to maintain the required GxP and high-quality standards. In this scenario, postponing all the regulatory audits indefinitely, is not a viable option. Effective continued oversite is required to maintain the quality standards of the products. So, the regulatory bodies are now turning to Virtual Audits.
Virtual Audits is a relatively new concept. USFDA has also just released the guidelines for them in April, 2021. This interactive forum will help us understand the difference between both types of audits and how can Virtual Audits be used as an effective tool to complement physical audits in the future.
Technology has been implemented at a brisk pace in the last 12 months. The best way to remain compliant is to adopt new innovations in our organisation. Let's discuss how can we leverage technological advancement to improve our regulatory compliance and become more efficient.
Eminence Business Media, brings this open forum, "Pharma Audit Readiness- Virtual & Physical", where you can put up your questions, participate in debates and get answers for the challenges faced by the teams and collectively implement the learnings.

Who Should Attend?

  • Know the recent guidelines released by USFDA about virtual Audits and their implementations from the expert.
  • Learn what regulators expect from us.
  • How to always be audit ready?
  • How to host a successful Virtual Audit?
  • Learn about the new technologies available to remain compliant and improve efficiency.
  • Difference between virtual & physical audits and how do they complement each other?

Attendee Profile

QA/QC Teams

Corporate Quality


Information Technology

Site Quality


Audit Compliance / Audit preparations

Who Should Attend?

  • Presidents
  • Vice Presidents
  • AVP's
  • Sr.GMs, GMs & AGMs
  • Mid Management


Dr. Mayur Parmar

Sr. Drug Inspector FDA (Gujarat)

Mr. Sachin Misra

Principal & Global Director Kalypso: A Rockwell Automation Company

Mr. K Kulbhushan

Global Head and Vice President - Operations Strategy and Excellence Dr. Reddy's Laboratories

Mr. SM Mudda

Managing Director Misom Labs

Ms. Chandana Yeluri

Head - Digital Transformation and Continuous Improvement Sandoz Development Center at Novartis

Mr. Sanjeev Dharwadkar

Sr. Director – External Manufacturing Sanofi

Mr. Arvind Thakkar

Technical Director Stallion Laboratories

Mr. Dilip Sawhney

Managing Director – India Rockwell Automation India Pvt. Ltd.


Platinum Partner

Rockwell Automation

Rockwell Automation Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 23,500 problem solvers dedicated to our customers in more than 100 countries. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit https://www.rockwellautomation.com/en-in.html

Media Partners

Choose Your Demo
You will find much more options for colors and styling in admin panel. This color picker is used only for demonstation purposes.
Purchase now